94 related articles for article (PubMed ID: 18888)
1. Interaction of dopaminergic and cholinergic neurons in the extrapyramidal and limbic systems.
Bartholini G; Stadler H; Gadea-Ciria M; Lloyd KG
Adv Biochem Psychopharmacol; 1977; 16():391-5. PubMed ID: 18888
[No Abstract] [Full Text] [Related]
2. Dopamine-acetylcholine-GABA neuronal linkages in the extrapyramidal and limbic systems.
McGeer PL; McGeer EG; Hattori T
Adv Biochem Psychopharmacol; 1977; 16():397-402. PubMed ID: 329651
[No Abstract] [Full Text] [Related]
3. Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems.
Bartholini G; Scatton B; Worms P; Zivkovic B; Lloyd KG
Adv Biochem Psychopharmacol; 1981; 30():119-28. PubMed ID: 6120626
[No Abstract] [Full Text] [Related]
4. Inhibition of dopaminergic activity in the extrapyramidal and limbic systems by gamma-acetylenic GABA [proceedings].
Huot S; Lippert B; Palfreyman MG; Schechter PJ
Br J Pharmacol; 1977 Jun; 60(2):264P-265P. PubMed ID: 880435
[No Abstract] [Full Text] [Related]
5. [Recent data on the mode of action of neuroleptics].
Bartholini G
Actual Pharmacol (Paris); 1978; 30():35-47. PubMed ID: 28640
[No Abstract] [Full Text] [Related]
6. Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons.
Julou L; Scatton B; Glowinski J
Adv Biochem Psychopharmacol; 1977; 16():617-24. PubMed ID: 18904
[No Abstract] [Full Text] [Related]
7. The dopamine hypothesis of schizophrenia and the antagonistic action of neuroleptic drugs--a review.
Sayed Y; Garrison JM
Psychopharmacol Bull; 1983; 19(2):283-8. PubMed ID: 6135238
[No Abstract] [Full Text] [Related]
8. Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function.
Bartholini G
Adv Biochem Psychopharmacol; 1977; 16():607-11. PubMed ID: 18902
[No Abstract] [Full Text] [Related]
9. Functions of dopamine in the extrapyramidal and limbic systems. Clues for the mechanism of drug actions.
Di Chiara G; Morelli M; Acquas E; Carboni E
Arzneimittelforschung; 1992 Feb; 42(2A):231-7. PubMed ID: 1586394
[TBL] [Abstract][Full Text] [Related]
10. Effect of the new gamma-aminobutyric acid agonist SL 76 002 on striatal acetylcholine: relation to neuroleptic-induced extrapyramidal alterations.
Bartholini G; Scatton B; Zivkovic B
Adv Biochem Psychopharmacol; 1980; 24():207-13. PubMed ID: 6105775
[TBL] [Abstract][Full Text] [Related]
11. Interelationships between dopaminergic and cholinergic systems in the cerebral cortex.
Mantovani P; Bartolini A; Pepeu G
Adv Biochem Psychopharmacol; 1977; 16():423-7. PubMed ID: 883550
[No Abstract] [Full Text] [Related]
12. Cholinergic pathways.
Shute CC; Lewis PR
Pharmacol Ther B; 1975; 1(1):79-87. PubMed ID: 772701
[No Abstract] [Full Text] [Related]
13. The importance of the ascending dopaminergic systems to the extrapyramidal and mesolimbic brain areas for the cataleptic action of the neuroleptic and cholinergic agents.
Costall B; Naylor RJ
Neuropharmacology; 1974 May; 13(5):353-64. PubMed ID: 4607196
[No Abstract] [Full Text] [Related]
14. Behavioral implications of dopaminergic neurons in the mesolimbic system.
Iversen SD; Koob GF
Adv Biochem Psychopharmacol; 1977; 16():209-14. PubMed ID: 560790
[No Abstract] [Full Text] [Related]
15. [Antipsychotic drug modification of motor hyperactivity and stereotyped behavior induced by amphetamine in rats with lesions in the nigrostriatal and mesolymbic dopaminergic systems].
Sánchez-Blázquez P; Fernández-Tomé MP; Fuentes JA; del Río J
Arch Farmacol Toxicol; 1978 Apr; 4(1):66-8. PubMed ID: 29574
[No Abstract] [Full Text] [Related]
16. [Cholinergic pathways of the central nervous system (author's transl)].
Nistri A
Riv Patol Nerv Ment; 1974 Aug; 95(4):203-14. PubMed ID: 4470242
[No Abstract] [Full Text] [Related]
17. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
Gygi SP; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
[TBL] [Abstract][Full Text] [Related]
18. Central monoaminergic pathways with emphasis on their relation to the so called 'extrapyramidal motor system'.
Fuxe K; Hökfelt T; Olson L; Ungerstedt U
Pharmacol Ther B; 1977; 3(2):169-210. PubMed ID: 413120
[No Abstract] [Full Text] [Related]
19. Cholinergic synapses in the limbic system and behavioral inhibition.
Grossman SP
Res Publ Assoc Res Nerv Ment Dis; 1972; 50():315-26. PubMed ID: 4341951
[No Abstract] [Full Text] [Related]
20. Serotonergic-dopaminergic interactions and extrapyramidal function.
Chase TN
Adv Biochem Psychopharmacol; 1974; 11(0):377-85. PubMed ID: 4367649
[No Abstract] [Full Text] [Related]
[Next] [New Search]
